The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $101.43

Today's change+0.32 +0.32%
Updated September 3 2:14 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $101.43

Today's change+0.32 +0.32%
Updated September 3 2:14 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp up (U.S.)$0.32

CVS Health Corp is up today by (U.S.)$0.32 or 0.32% to (U.S.)$101.43. Shares have lost 3.58% over the last five days, but have gained 5.32% over the last year to date. This security has outperformed the S&P 500 by 28.83% during the last year.

Key company metrics

  • Open(U.S.) $101.81
  • Previous close(U.S.) $101.11
  • High(U.S.) $102.83
  • Low(U.S.) $101.31
  • Bid / Ask(U.S.) $101.40 / (U.S.) $101.43
  • YTD % change+5.32%
  • Volume2,581,057
  • Average volume (10-day)7,576,837
  • Average volume (1-month)5,687,449
  • Average volume (3-month)4,740,388
  • 52-week range(U.S.) $77.40 to (U.S.) $113.65
  • Beta0.88
  • Trailing P/E24.37×
  • P/E 1 year forward19.62×
  • Forward PEG1.31×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield1.38%
  • Trailing EPS(U.S.) $4.16
Updated September 3 2:14 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.27%

Based on its net profit margin of 3.27%, CVS Health Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.17%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue37,16936,33237,05535,021
Total other revenue--------
Total revenue37,16936,33237,05535,021
Gross profit6,4026,1646,6336,468
Total cost of revenue30,76730,16830,42228,553
Total operating expense34,90734,20034,73433,296
Selling / general / administrative4,1404,0324,3124,222
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----0521
Other operating expenses, total--------
Operating income2,2622,1322,3211,725
Interest income (expense), net non-operating-171-137-135-158
Gain (loss) on sale of assets--------
Other--------
Income before tax2,0961,9982,1901,572
Income after tax1,2721,2211,322948
Income tax, total824777868624
Net income1,2721,2211,321948
Total adjustments to net income--------
Net income before extra. items1,2721,2211,322948
Minority interest----0--
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,2721,2211,322948
Inc. avail. to common incl. extra. items1,2721,2211,321948
Diluted net income1,2721,2211,321948
Dilution adjustment--------
Diluted weighted average shares1,1321,1361,1511,164
Diluted EPS excluding extraordinary itemsvalue per share1.121.071.150.81
Dividends per sharevalue per share0.350.350.280.28
Diluted normalized EPSvalue per share1.121.071.151.08